Active site titration of pig pancreatic kallikrein with p-nitrophenyl p′-guanidinobenzoate  by Fiedler, F. et al.
Volume 24, number 1 FEBS LETTERS July 1972 
ACTIVE SITE TITRATION OF PIG PANCREATIC KALLIKREIN 
WITH p-NITROPHENYL p’-GUANIDINOBENZOATE 
F. FIEDLER, B. MULLER and E. WERLE 
Institut ftir Klinische Chemie und Klinische Biochemie der Universittit, 8 Miinchen 2, Nussbaumstr. 20, Germany 
Revised version received 17 May 1972 
1. htroduction 
Kallikrein (EC 3.4.4.2 1; the enzyme from porcine 
pancreas is understood throughout this paper) forms 
acyl-enzymes in the reactions with diisopropyl fluoro- 
phosphate [ 1 ] or cinnamoyl and indoleacryloyl imid- 
azoles [2]. Concerning the hydrolytic mechanism of 
ester cleavage by kallikrein, studies on the hydrolysis 
of a number of arginine esters with different alcohol 
moieties failed to reveal the operation of an acyl- 
enzyme mechanism [3] . In the present report, prop- 
erties of p-nitrophenyl p’-guanidinobenzoate (pNPGB) 
as a kallikrein substrate are described. This compound 
allows the demonstration of acyl-enzyme formation 
by monitoring the liberation of p-nitrophenol. Similar 
to other enzyme systems [4-61, pNPGB proved a 
useful reagent for the active site titration of kallikrein. 
The present work also leads to a revised value for the 
molecular weight of the enzyme. 
2. Materials and methods 
pNPGB-HCl was obtained from Cycle Chemical 
Corp. pNitropheno1, a Merck p.a. product, was twice 
recrystallized from toluene. A sample of this material 
was further recrystallized from water. Kallikrein was 
purified from prepurified preparations from pig pan- 
creastic autolysates generously supplied by Farben- 
fabriken Bayer AG by the procedure of Fritz et al. [7] 
modified by application of a buffer gradient. The 
material obtained was treated with sialidase [7] and 
separated on DEAE-cellulose into the kallikrein A and 
B [8] which were further purified by rechromatog- 
raphy and gel filtration on Sephadex G-50. The spe- 
cific activity of the preparations was determined with 
ol-N-benzoyl-L-arginine thyl ester as substrate as 
described in [9] . 
Active site titrations of kallikrein were conducted 
on a Cary 15 spectrophotometer equipped with a 
O-O. 1 slide wire and cuvette holders thermostated at 
25.0”. The sample cuvette of 1 cm light path con- 
tained 1.93 ml 0.1 M veronal buffer, pH 8.3, 1 mM in 
EDTA [lo] , which had been filtered through a Sartorius 
membrane filter SM 11309 of 0.1 pm pore diameter. 
20 ~1 of a 4- 10 mM solution of pNPGB in acetoni- 
trile/water (4: 1 v/v) were added, and the absorbance at 
402 nm was recorded for several minutes. Then 50 ~1 
of an aqueous solution of kallikrein (about 4 nmoles) 
were added. In general, every third experiment was 
conducted in an inverse manner, starting the reaction 
by the addition of substrate. Experiments aiming at 
the determination of the acylation constant were run 
on a Gibson-Durrum stopped flow spectrophotometer 
equipped with a cuvette of 2 cm light path, thermo- 
stated at 25”. One syringe contained a solution of 
kallikrein B (about 2 PM) in the above verqnal buffer 
and the other an aqueous solution of pNPGB. 
3. Results and discussion 
On addition of kallikrein to a solution of pNPGB, 
an initial rapid liberation (“burst”) of nitrophenol 
followed by a steady-state reaction occurs (fig. 1). 
Such a biphasic nitrophenol production is accounted 
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Fig. 1. Reaction of kallikrein A (1.87 rM) with pNPGB (100 PM) at pH 8.3. At -65 set the substrate solution was added and at 
0 set the reaction was started by the addition of enzyme. The dotted line shows the extrapolation back to zero time to obtain the 
burst n. 
for by the reaction scheme 
KS k2 k3 
E+SZ ES-P, +ES*-+ P2 tE, 
the “burst” reflecting the initial formation of acyl- 
enzyme ES* (see [ 1 l] ). This experimental observa- 
tion thus establishes the operation of an acyl-enzyme 
mechanism in the kallikrein catalyzed hydrolysis of an 
ester substrate. 
The quantitative treatment of the reaction for the 
case [S] s [El0 and k2 S k3 applying here has been 
given by Bender et al. [ 12,131. From the first order 
acylation phase followed on the Gibson-Durrum in- 
strument with [S] ranging from 40 to 100 yM, values 
ofka =18?7 set-’ andK,=81*56pM(n=4)were 
obtained for kallikrein B. There is no dependence of 
the postburst nitrophenol production rate on [S] in 
the concentration range examined in the experiments 
carried out with the Cary instrument, indicating [S] s 
SK,,, . “Nonspecific nitrophenol production” [4,5] is 
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excluded, since a preparation of kallikrein B inhibited 
by 48% (substrate: a-N-benzoyl-L-arginine ethyl ester) 
by controlled treatment with diisopropyl fluorophos- 
phate exhibited a steady-state hydrolysis rate of 
pNPCB 47% slower than native enzyme. Thus the 
observed rate of p-nitrophenol production (after a 
nearly negligible correction for spontaneous hydrolysis 
of pNPCB) equals k3, it being (1.76 + 0.06). lo-’ set-’ 
for kallikreins A and B. k3 is much higher than the 
values reported for the hydrolysis of pNPCB by tryp- 
sin, thrombin, or plasmin [5], and is about as large as 
k3 with chymotrypsin [4]. K,,, =K,. k3/(kz +k,) is 
calculated as 79 f 63 nM for kallikrein B. 
In spite of the rather high value of k3, back extra- 
polation to zero time to obtain the burst ‘II is easily 
possible (fig. 1). As kz 3 k3 and [S] SK,, the con- 
centration of kallikrein active sites may be taken 
directly from n after applying a small correction for 
changes in absorbance caused by the addition of ab- 
sorbing reagent solutions or their dilution. The results 
of a number of titrations of different batches of 
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Table 1 
Titration of different batches of kallikreins A and B with pNPGB. [E]o, concentration of enzymatically active kallikrein in the 
cuvette; n, number of titrations conducted; [E] T, concentration of active sites obtained by titration. 
Specific 
activity 
(Umg 
protein) 
Flo 
(WnJ) 
n ll?rcI 
(low3 absor- 
bance units) 
FIT 
(PM) 
Catalytic 
center 
activity 
(mm’) 
KaBikrein A 240 13.4 7 32.2 r 0.46 1.87 7 150 
Kallikrein B 234 11.3 9 26.6 f 0.21 1.54 7 370 
Kallikrein B 262 13.7 6 32.2 f 0.14 1.87 7 330 
Kalhkrein B 300 15.3 5 37.1 f 0.26 2.15 7 120 
KaBikrein B 308 11.6 6 28.7 f 0.46 1.66 6 980 
kallikrein of different specific activities are compiled 
in table 1. The enzyme solutions used in the first three 
experiments had been filtered through membrane fil- 
ters. This treatment decreased the initial specific activ- 
ities by about 10%. Therefore, filtration was omitted 
in the last two experiments. Titration results obtained 
with pNPCB concentrations between 40 and 100 PM 
were identical, as is to be expected because of the very 
low K, . Identical results were also obtained in inverse 
titrations. The small standard error of 7~ demonstrates 
the very satisfactory reproducibility of the measure- 
ments. 
Because of the importance of the molar absorbance 
of p-nitrophenol for the evaluation of the titration 
results, it has been redetermined under the conditions 
of the titration experiments. At the absorbance maxi- 
mum at 402 nm a value of 17,230 f 110 M-’ cm’ (n = 
8) at pH 8.3 was obtained, in excellent agreement 
with data calculated from the literature [4,14]. Both 
recrystallized p-nitrophenol sample had identical ab- 
sorbance. The presence of 0.8% (v/v) acetonitrile or 
of kallikrein in a concentration equimolar to that of 
p-nitrophenol did not influence absorbance at 402 nm. 
The mean value of the catalytic center activity of 
kallikrein B in a-N-benzoyl-L-arginine ethyl ester 
hydrolysis, 7200 + 92 min-’ , is identical to that of 
kallikrein A. It was not possible to increase the spe- 
cific activity of kallikreins A or B beyond a limit of 
300 + 10 U/mg protein by further purification oper- 
ations. This value, in combination with the titration 
results and the evidence for a single active site in kal- 
likrein [ 1 ] , allows a calculation of the molecular 
weight of the protein moiety of the kallikrein mole- 
cule which results as 24,000 f 860 for both forms of 
the enzyme. With an average value of 7% for the car- 
bohydrate content of kallikrein [7], the molecular 
weight emerges as 25,700 ? 920. 
Based on a value of 35,000 obtained from gel fil- 
tration experiments [ 151, which is confirmed by 
Takami [ 161 who found 34,000, the molecular 
weight of sialic acid free kallikrein has been calculated 
from the amino acid and carbohydrate composition as 
33,400 to 33,800 [7]. It is well known, however, that 
during gel filtration glyceroproteins tend to behave as 
proteins with a higher than the true molecular weight 
v71. 
Several ultracentrifugation studies on the molecular 
weight of kallikrein are reported in the literature. 
Habermann [ 181 obtained a value of 23,000 to 24,000. 
Moriya revised his earlier result of 33,000 [ 191 in a 
recent paper to 25,200 [20]. According to the method 
of Cohn and Edsall [2 1 ] , a value of 0.72 1 ml/g can be 
calculated for the partial specific volume F of kallikrein 
from its amino acid and carbohydrate composition [7] 
and the specific volumes of the residues compiled in 
[21-231. If one recalculates the molecular weight de- 
termined by Scholtan [7] using i; = 0.721 in place of 
0.749, a value of 26,100 (instead of 29,000) results. 
Thus, the divergent ultracentrifugation results of the 
different authors appear to converge now at a value 
around 25,000. This is in good agreement with the 
molecular weight of kallikrein derived from the pres- 
ent active site titration data. 
The molecular weight of the protein moiety of 
kallikrein determined here is close to that of other 
pancreatic serine proteinases [24] to which kallikreins 
A and B evidently bear a close resemblance also in 
this respect. 
43 
Volume 24, number 1 FEBS LETTERS July 1972 
Acknowledgements 
Our thanks are due to the Institut ftir Physiolo- 
gische Chemie und Physikalische Biochemie and to the 
Pharmakologisches Institut der Universitgt Miinchen 
for permission to use their Cary 15 and Gibson- 
Durrum instruments, respectively. This work was 
sponsored by Deutsche Forschungsgemeinschaft (Son- 
derforschungsbereich 51). 
[lOI 
1111 
1121 
[131 
1141 
I151 
References [161 
[II 
(21 
[31 
141 
[51 
[61 
171 
[81 
I91 
F. Fiedler, B. Mtiller and E. Werle, European J. Biochem. 
10 (1969) 419. 
F. Fiedler, B. Midler and E. Werle, FEBS Letters 22 
(1972) 1. 
[171 
[181 
[191 
E. Werle and F. Fiedler, Biochem. J. 115 (1969) 4 P. [201 
T. Chase, Jr. and E. Shaw, Biochem. Biophys. Res. Commun. 
29 (1967) 508. I211 
T. Chase, Jr. and E. Shaw, Biochemistry 8 (1969) 2212. 
J.B. Baird and D.T. Elmore, FEBS Letters 1 (1968) 343. 
H. Fritz, 1. Eckert and E. Werle, Z. physiol. Chem. 348 [221 
(1967) 1120. 
F. Fiedler and E Werle, Z. physiol. Chem. 348 (1967) 
1087. 
F. Fiedler. B. Miiller and E. Werle, Z. physiol. Chem. 352 
1231 
(1971) 1463. 
F. Fiedler and E. Werle, European J. Biochem. 7 (1968) 
27. 
M.L. Bender and F.J. Kdzdy, Ann. Rev. Biochem. 34 
(1965) 49. 
M.L. Bender, F.J. Kdzdy and F.C. Wedler, J. Chem. 
Education 44 (1967) 84. 
M.L. Bender, M.L. Beg&-Cant&, R.L. Blakeley, 
L.J. Brubacher, J. Feder, C.R. Gunter, F.J. Keidy, 
J.V. Killheffer, Jr., T.M. Marshall, C.G. Miller, R.W. Roeske 
and J.K. Stoops, J. Amer. Chem. Sot. 88 (1966) 5890. 
F.J. Kezdy and M.L. Bender, Biochemistry 1 (1962) 1097. 
H. Fritz, 1. Trautschold and E. Werle, Z. physiol. Chem. 
342 (1965) 253. 
T. Takami, J. Jap. Biochem. Sot. (Seikagabu) 41 (1969) 
777. 
P. Andrews, Methods of Biochem. Analysis 18 (1970) 1. 
E. Habermann, Z. physiol. Chem. 328 (1962) 15. 
H. Moriya, J. Pharmacol. Sot. Japan (Yakugaku zasshi) 
79 (1959) 1451. 
H. Moriya, A. Kato and H. Fukushima, Biochem. Phar- 
macol. 18 (1969) 549. 
E.J. Cohn and J.T. Edsall, Proteins, Amino Acids and 
Peptides (Reinhold Publishing Corp., New York, 1943) 
p. 370. 
H.K. Schachman, in: Methods in Enzymology, Vol. IV, 
cds. S.P. Colowick and N.O. Kaplan (Academic Press 
Inc., New York, 1957) p.32. 
R.A. Gibbons, in: Glycoproteins, ed. A. Gottschalk 
(Elsevier Publishing Comp., Amsterdam, London, New 
York, 1966) p. 29. 
T.E. Barman, Enzyme Handbook Vol. II (Springer- 
Verlag, Berlin, Heidelberg, New York, 1969). 
44 
